Beruflich Dokumente
Kultur Dokumente
Nursing Department
CASE ANALYSIS
MASSIVE ASCITES
Submitted By:
Kristelle P. Dacuscus
Submitted To:
Ascites refers to the abnormal (pathologic) build up of fluid in the peritoneal (abdominal) cavity.
Normally there should be almost no fluid here (i.e., surrounding the intestines and organs such as the liver
and spleen). Ascites occurs because of one of four general problems: 1) there is a disease in the peritoneal
cavity that is producing excessive fluid (e.g., infections or cancer); 2) there is fluid back up from the liver
or large blood vessels into the peritoneal cavity -- known as portal hypertension; 3) low protein state in the
body; and 4) miscellaneous.
II DEMOGRAPHIC INFORMATION
This is the case of Patient Z, a 31 years old male, single, born on July 29, 1978 and presently
residing at Bauang, La Union. He is engineering instructor in one of the college school in La Union. He
was admitted on November 25, 2009 @ 4:30 pm @ Ilocos Regional Training and Medical Center (ITRMC)
with the chief complaints of difficulty of breathing.
This is the second time the patient was admitted @ ITRMC. Patient Z has a history of childhood
asthma, and was diagnosed with Diabetes Mellitus (DM) last year (2008) and with liver cirrhosis last
month (October 2009).
The patient condition started about two weeks PTA where the patient went to the OPD @ ITRMC
regarding increased in the size of abdomen. Ultrasound findings revealed liver cirrhosis. He was given
spironolactone 100 mg 1 tab. OD and propanolol 10 mg 1 tab. OD for relief. A noticeable edema unto the
facial area with gradual enlargement of the abdomen where patient has episode of difficulty of breathing.
One day prior to admission, patient complaints of fever and chills (undocumented) where he has painful
urination. No medicines taken, no consult was done. Patient still have anasarca with difficulty of breathing.
Persistence of condition prompted. Consulted and hence admitted.
IV.SIMPLE PATHOPHYSIOLOGY (paradigm)
>age
cirrhosis
hypoalbuminemia
>promotes excretions of
>Administered diuretics as fluids.
ordered.
Nursing Problem: changes in body image
>changes in
social
involvement
>provides opportunity for
istening to concerns and
>jaundice os >Visited client frequently & questions.
the skin and acknowledge the individual as
sclera someone who is worthwhile.
Nursing Problem: body weakness
1. SPIRONOLACTONE
>aldactone, novospirotone
Action: Potassium-sparing diuretics; antagonizes aldosterone in the distal tubules, increasing sodium & water
excretion.
2. FUROSEMIDE
>Apo-Furosemide, Furoside
Action: A potent loop that inhibits sodium & chloride reabsorption @ the proximal distal tubules & ascending loop
of Henle.
3. PROPANOLOL HYDROCHLORIDE
>Apo-propanolol, Deralin
10mg/tab TID
Action: A non selective beta-blocker that reduces cardiac oxygen demand by blocking catecholamine-induced
increases in heart rate, BP, and force of myocardial contraction. Depresses renin secretion and prevents vasodilation
of cerebral arteries.
Indications: angina pectoris, to decrease risk of death after MI, suprventricular; ventricular and arterial arrhythmias,
hyperthyroidism, hypertension,to prevent frequent severe uncontrollable or disabling migraine or vascular headache,
essential tremor, hypertropic subaortic stenosis, adjunct therapy in pheochromocytoma.
4. CIPROFLOXACIN
>Cipro, Ciproxin
Action: Inhibits bacterial DNA synthesis, mainly by blocking DNA gyrase; bactericidal.
Indications: Mild to moderate UTI, severe or complicated UTI, chronic bacterial prostatitis, complicated intra-
abdominal infections, acyte complicated cystitis, inhalation anthrax ( postexposure).
VII.RECOMENDATIONS/CONCLUSION
Liver disease can manifest in many different ways. Characteristic manifestations include
jaundice (a yellowish discoloration of the skin and whites of the eyes), cholestasis (reduction or
stoppage of bile flow), liver enlargement, portal hypertension (abnormally high blood pressure in
the veins that bring blood from the intestine to the liver), ascites (accumulation of fluid in the
abdominal cavity), hepatic encephalopathy (deterioration of brain function due to buildup of
toxic substances normally removed by the brain), and liver failure.
Sometimes the manifestations of liver disease are not obvious. For example, symptoms
may include fatigue, a feeling of unwellness, loss of appetite, and mild weight loss. However,
these symptoms are also typical of many other diseases. Thus, liver disease can easily be
overlooked, particularly in its early stages.
In people with a liver disorder, ascitic fluid leaks from the surface of the liver and
intestine. A combination of factors is responsible. They include portal hypertension, decreased
ability of the blood vessels to retain fluid, fluid retention by the kidneys, and alterations in
various hormones and chemicals that regulate bodily fluids
VIII.PROGNOSIS
The predicted outcome depends on the underlying disease process. Since ascites is
usually caused by a chronic, progressive disease process, the outlook is not good unless
something can be done to correct the underlying disease. Of those with ascites secondary to liver
failure, 50% will die within 2 years regardless of therapeutic intervention.
Therapeutic paracentesis is safe and effective in removing small to moderate amounts of
ascitic fluid. Because this procedure carries the risk of abdominal infection and can cause low
blood pressure or shock, it may not be appropriate for those with severe or refractory ascites.
Peritoneovenous shunting is effective in reducing the ascites but carries an operative mortality
rate of up to 30%. While relatively new, TIPS is a procedure that effectively reduces ascites in
over 50% of the cases without the risk of surgery. However, following the TIPS procedure, over
30% developed shunt failure due to occlusion, and over 20% developed metabolic brain
dysfunction (encephalopathy).
Outcome and survival vary following liver transplantation. The 6-month survival after
liver transplantation in clinically stable individuals with chronic liver failure is as high as 90%.
Critically ill individuals at the time of transplantation have a 6-month survival of only 65%